Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Apr 10, 2024 (filed on Apr 11, 2024)Insider Name:Moran Sean F.Ownership Type:Direct OwnershipSecurities:Employee Stock Option (right to buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,787Price:--
-
Apr 10, 2024 (filed on Apr 11, 2024)Insider Name:Moran Sean F.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:1,787Price:$30.00
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:156,597Price:$45.26
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:61,668Price:$44.62
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:18,548Price:$43.26
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:24,983Price:$42.25
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:29,342Price:$41.23
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:8,862Price:$45.96
-
Mar 07, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:102,140Price:$41.23
-
Mar 07, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:90,325Price:$39.99
Filings by filing date
-
Apr 10, 2024 (filed on Apr 11, 2024)Insider Name:Moran Sean F.Ownership Type:Direct OwnershipSecurities:Employee Stock Option (right to buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,787Price:--
-
Apr 10, 2024 (filed on Apr 11, 2024)Insider Name:Moran Sean F.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:1,787Price:$30.00
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:156,597Price:$45.26
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:61,668Price:$44.62
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:18,548Price:$43.26
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:24,983Price:$42.25
-
Mar 08, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:29,342Price:$41.23
-
Mar 07, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:102,140Price:$41.23
-
Mar 07, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:90,325Price:$39.99
-
Mar 07, 2024 (filed on Mar 11, 2024)Insider Name:Cormorant Asset Management, LPOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:10,736Price:$39.13
News
Biz Brief
Sector: Healthcare | Industry: Biotechnology & Medical Research |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 500 River Ridge Drive NORWOOD MA 02062 |
Tel: | N/A |
Website: | https://www.corbuspharma.com |
IR: | See website |
Key People | ||
Yuval Cohen Chief Executive Officer, Director | Sean F. Moran Chief Financial Officer | Dominic Smethurst Chief Medical Officer |
Business Overview |
N/A |
Financial Overview |
For the fiscal year ended 31 December 2023, Corbus Pharmaceuticals Holdings Inc revenues was not reported. Net loss increased 5% to $44.6M. Higher net loss reflects Research and development - Balancing va increase of 98% to $30.8M (expense), Interest income,Net increase of 37% to $2.9M (expense), FV/Uls Adjust on Derivatives for Hedging decrease from $97K (income) to $3K (expense). |
Employees: | 19 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $391.85M as of Dec 31, 2023 |
Annual revenue (TTM): | $0.00M as of Dec 31, 2023 |
EBITDA (TTM): | -$44.44M as of Dec 31, 2023 |
Net annual income (TTM): | -$44.60M as of Dec 31, 2023 |
Free cash flow (TTM): | -$36.10M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 10,507,237 as of Mar 22, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |